Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 125

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 125
---
                                 | 2,656,596 |     |   |  48.9 |     |     | 3,123,593 |     |   |  60.8 |
| Cambodia       |     |                                 |   601,526 |     |   |  11.1 |     |     |   621,619 |     |   |  12.1 |
| Thailand       |     |                                 | 2,175,253 |     |   |  40.0 |     |     | 1,356,903 |     |   |  26.4 |
| Total revenues |     |                                 | 5,433,375 |     |   | 100.0 |     |     | 5,136,153 |     |   | 100.0 |

NewGenIvf’s revenue
results are affected by, among others, changes in sales price and the fluctuation of foreign currency rates with US dollars. A 5% change
in sales price would cause 5% change in NewGenIvf’s revenue. Based on the breakdown of the revenue contribution in terms of currencies
used by customers for 2024, a 5% change in foreign currency rates with US dollars would cause approximately 2.4% change in NewGenIvf’s
revenue.

<div align='center'>72</div>

IVF treatment services

NewGenIvf generated revenue
from IVF treatment services provided at facilities that NewGenIvf operated in Thailand and Cambodia. In addition, NewGenIvf also recognized
revenues from IVF treatments included in surrogacy services performed in Kyrgyzstan. NewGenIvf’s revenue from IVF treatment service
amounted to US$5,433,375 and US$4,021,696, representing approximately 100% and 78.3% of its total revenues in 2024 and 2023, respectively.

IVF treatment involves the
performance of a series of medical treatment and procedures and eventually brings benefits to clients when embryo is successfully implanted.
Revenue from IVF treatment is recognized at a point in time when different treatment and/or procedure completed in clinic. The completion
of the respective treatments and/or procedures are evidenced by treatment cards and reports maintained in the patient files indicating
successful completion of respective promised obligations.

Surrogacy and ancillary caring services

NewGenIvf also generated revenue
of US$1,114,457 from sur